Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?When is the expected fda decision date for apotex's ruxolitinib resubmission?How does iron rich food intake impact lipitor's efficacy?Dabrafenib patent expiration?When will tenofovir alafenide come off patent in canada?
See the DrugPatentWatch profile for Fabrazyme
Fabrazyme is manufactured by Sanofi Genzyme, a Sanofi company. Fabrazyme’s active ingredient is agalsidase beta, an enzyme replacement therapy used to treat Fabry disease.
On the prescribing information (and packaging), Fabrazyme’s manufacturer is listed as Sanofi Genzyme. If you’re checking for a specific country or presentation (for example, vials by strength), the label will also show the local distributor or marketing authorization holder for that market.
Yes. Even when the drug product is made by the same pharmaceutical manufacturer, the name you see can differ by market because some countries list a local distributor or marketing authorization holder in addition to the manufacturing company.
If you’re looking for manufacturer or supply details tied to exclusivity/patents, DrugPatentWatch.com is one place to cross-check related filings and ownership information for Fabrazyme. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Fabrazyme :